Lebanon vs Northern Africa and Western Asia: Percentage of bloodstream infection due to methicillin-resistant
Lebanon
52.5%
in 2022
Northern Africa and Western Asia
42.1%
in 2022
Lebanon rank
11th
Northern Africa and Western Asia rank
8th
Percentage of bloodstream infection due to methicillin-resistant over time
- Lebanon
- Northern Africa and Western Asia
How they compare
Lebanon currently reports 52.5% against 42.1% in Northern Africa and Western Asia, a difference of 10.4%.
That makes Lebanon's figure about 1.2 times Northern Africa and Western Asia's.
The two have swapped places 1 time across 6 shared years of data; in 2017 it was Northern Africa and Western Asia ahead.
Lebanon ranks 11th and Northern Africa and Western Asia ranks 8th of 50 countries.
Northern Africa and Western Asia has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Lebanon | Northern Africa and Western Asia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 17.8% | 33.9% | 16.2% | Northern Africa and Western Asia |
| 2020s | 41.6% | 44.4% | 2.8% | Northern Africa and Western Asia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher percentage of bloodstream infection due to methicillin-resistant, Lebanon or Northern Africa and Western Asia?
- Lebanon, at 52.5% against 42.1% in Northern Africa and Western Asia as of 2022.
- What is the difference in percentage of bloodstream infection due to methicillin-resistant between Lebanon and Northern Africa and Western Asia?
- 10.4%, with Lebanon ahead.
- How many years of comparable data are there for Lebanon and Northern Africa and Western Asia?
- 6 years are reported by both, from 2017 to 2022.
- How do Lebanon and Northern Africa and Western Asia rank globally for percentage of bloodstream infection due to methicillin-resistant?
- Lebanon ranks 11th and Northern Africa and Western Asia ranks 8th of 50 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.